EMA data disclosure policy needs a rethink, says industry
This article was originally published in Scrip
Executive Summary
Comments submitted by the European industry federation EFPIA give some indication of the challenges facing the European Medicines Agency if it is to finalise and implement its new policy on the publication of clinical trial data by the 1 January 2014 deadline.